| Product Code: ETC10738245 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Orphan Drug Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Orphan Drug Market Revenues & Volume, 2021 & 2031F |
3.3 China Orphan Drug Market - Industry Life Cycle |
3.4 China Orphan Drug Market - Porter's Five Forces |
3.5 China Orphan Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 China Orphan Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 China Orphan Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Orphan Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in China |
4.2.2 Government support and incentives for orphan drug development |
4.2.3 Growing healthcare expenditure and awareness about orphan drugs |
4.3 Market Restraints |
4.3.1 Lengthy and costly approval process for orphan drugs in China |
4.3.2 Limited understanding and awareness among healthcare professionals about orphan drugs |
5 China Orphan Drug Market Trends |
6 China Orphan Drug Market, By Types |
6.1 China Orphan Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Orphan Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China Orphan Drug Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 China Orphan Drug Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 China Orphan Drug Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.6 China Orphan Drug Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.7 China Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Orphan Drug Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 China Orphan Drug Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 China Orphan Drug Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.2.4 China Orphan Drug Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.5 China Orphan Drug Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.6 China Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 China Orphan Drug Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Orphan Drug Market Revenues & Volume, By Prescription Drugs, 2021 - 2031F |
6.3.3 China Orphan Drug Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.3.4 China Orphan Drug Market Revenues & Volume, By Specialty Drugs, 2021 - 2031F |
6.3.5 China Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3.6 China Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 China Orphan Drug Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Orphan Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 China Orphan Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 China Orphan Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 China Orphan Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.6 China Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Orphan Drug Market Import-Export Trade Statistics |
7.1 China Orphan Drug Market Export to Major Countries |
7.2 China Orphan Drug Market Imports from Major Countries |
8 China Orphan Drug Market Key Performance Indicators |
8.1 Number of orphan drug designations granted by the China Food and Drug Administration |
8.2 Investment in research and development for orphan drugs in China |
8.3 Number of clinical trials for orphan drugs conducted in China |
9 China Orphan Drug Market - Opportunity Assessment |
9.1 China Orphan Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Orphan Drug Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 China Orphan Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 China Orphan Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Orphan Drug Market - Competitive Landscape |
10.1 China Orphan Drug Market Revenue Share, By Companies, 2024 |
10.2 China Orphan Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here